Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids

Table 3

The concentrations of PTH, calcium, and phosphorus in the studied groups during relapse and remission.

		PTH (pg/ml) M (25Q, 75Q) min-max	Calcium (mg/dl) M (25Q, 75Q) min-max	Phosphorus (mg/dl) M (25Q, 75Q) min-max
Control group ()		82.2 (80.8,83.3) 80.2-84.4	9.91 (9.80, 9.99) 9.54-10.42	4.73 (4.60, 5.10) 3.54-5.40
Group I ()	First occurrence	108.0 (105.7,109.7) 104.5-111.0	8.61 (8.10, 8.82) 8.00-9.38	4.49(2.80, 5.50) 1.90-6.34
	Remission	98.6 (98.0, 99.3) 96.8-100.6	—	—
Group II ()	Relapse	117.2 (116.1, 118.9) 114.4-119.6	9.18 (8.40, 9.64) 7.84-10.03	4.67 (4.00, 5.00) 2.16-5.30
	Remission	—	—	—
Group III ()	Relapse	138.0 (137.4, 138.9) 136.7-139.0	8.40 (8.00, 9.60) 7.44-9.90	5.00 (3.90, 5.50) 3.30-7.30
	Remission	123.2 (123.0, 124.3) 122.4-124.4	—	—
Group IV ()	Relapse	—	—	—
	Remission	132.2 (131.5, 133.0) 130.3-133.6	9.78 (9.24,10.00) 8.01-10.50	4.30 (4.10, 4.68) 3.90-5.71

Data are presented as median values, quartiles (first and third), and range (minimum and maximum values).